These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses]. Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M Encephale; 1995; 21(6):417-24. PubMed ID: 8674466 [TBL] [Abstract][Full Text] [Related]
10. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays. Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338 [No Abstract] [Full Text] [Related]
11. Haloperidol dose, plasma levels, and clinical response: a double-blind study [proceedings]. Ericksen SE; Hurt SW; Chang S Psychopharmacol Bull; 1978 Apr; 14(2):15-6. PubMed ID: 349597 [No Abstract] [Full Text] [Related]
12. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder. Volavka J; Cooper TB; Czobor P; Meisner M Psychopharmacol Bull; 1996; 32(1):75-9. PubMed ID: 8927679 [TBL] [Abstract][Full Text] [Related]
13. Does a therapeutic window for plasma haloperidol exist?: Preliminary Chinese data. Potkin SG; Shen YC; Zhou DF; Pardes H; Shu L; Phelps B; Poland R Psychopharmacol Bull; 1985; 21(1):59-61. PubMed ID: 3983339 [No Abstract] [Full Text] [Related]
14. Fluoxetine augmentation of haloperidol in chronic schizophrenia. Shim JC; Kelly DL; Kim YH; Yoon YR; Park JH; Shin JG; Conley RR J Clin Psychopharmacol; 2003 Oct; 23(5):520-2. PubMed ID: 14520132 [No Abstract] [Full Text] [Related]
15. Effect of chlorpromazine and clozapine on plasma concentrations of haloperidol in a patient with schizophrenia. Allen SA J Clin Pharmacol; 2000 Nov; 40(11):1296-7. PubMed ID: 11075316 [TBL] [Abstract][Full Text] [Related]
16. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state. Jibiki I; Kubota T; Fujimoto K; Sakamoto H; Hasegawa M; Furuta H; Yamaguchi N Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878 [No Abstract] [Full Text] [Related]
17. Treatment of acute and chronic psychoses with haloperidol: review of clinical results. Ban TA Curr Ther Res Clin Exp; 1969 May; 11(5):284-8. PubMed ID: 4977400 [No Abstract] [Full Text] [Related]
18. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome. Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795 [TBL] [Abstract][Full Text] [Related]
19. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia. Levinson I; Levine S Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667 [No Abstract] [Full Text] [Related]
20. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]